A Trypanosoma brucei Kinesin Heavy Chain Promotes Parasite Growth by Triggering Host Arginase Activity

50Citations
Citations of this article
70Readers
Mendeley users who have this article in their library.

Abstract

Background:In order to promote infection, the blood-borne parasite Trypanosoma brucei releases factors that upregulate arginase expression and activity in myeloid cells.Methodology/Principal findings:By screening a cDNA library of T. brucei with an antibody neutralizing the arginase-inducing activity of parasite released factors, we identified a Kinesin Heavy Chain isoform, termed TbKHC1, as responsible for this effect. Following interaction with mouse myeloid cells, natural or recombinant TbKHC1 triggered SIGN-R1 receptor-dependent induction of IL-10 production, resulting in arginase-1 activation concomitant with reduction of nitric oxide (NO) synthase activity. This TbKHC1 activity was IL-4Rα-independent and did not mirror M2 activation of myeloid cells. As compared to wild-type T. brucei, infection by TbKHC1 KO parasites was characterized by strongly reduced parasitaemia and prolonged host survival time. By treating infected mice with ornithine or with NO synthase inhibitor, we observed that during the first wave of parasitaemia the parasite growth-promoting effect of TbKHC1-mediated arginase activation resulted more from increased polyamine production than from reduction of NO synthesis. In late stage infection, TbKHC1-mediated reduction of NO synthesis appeared to contribute to liver damage linked to shortening of host survival time.Conclusion:A kinesin heavy chain released by T. brucei induces IL-10 and arginase-1 through SIGN-R1 signaling in myeloid cells, which promotes early trypanosome growth and favors parasite settlement in the host. Moreover, in the late stage of infection, the inhibition of NO synthesis by TbKHC1 contributes to liver pathogenicity.

Figures

  • Figure 1. Induction of myeloid cell arginase activity by T. brucei PRF. Arginase activity was determined in myeloid cells from non-infected mice incubated with (A) WT parasites separated or not by an insert, or WT parasite-released factors (PRF), (B) PRF from WT parasites in presence of indicated antibodies and (C) PRF from WT or TbKHC1 KO parasites, or material purified on anti-PRF antibody affinity column, in presence of indicated antibodies. Heat treatment was at 45uC for 30 min. Data are means 6 SEM of 3–4 individual mice of one representative from 3 independent experiments (A, B), or of triplicate cultures of one representative from 2 independent experiments (C). * p,0.05 compared to non-stimulated (-) cells. doi:10.1371/journal.ppat.1003731.g001
  • Figure 2. Expression and localization of T. brucei TbKHC1. (A) Detection of TbKHC1 transcripts by Northern blotting of RNA from procyclic forms (PF), bloodstream (BF) slender (SL) and stumpy (ST) forms, BF TbKHC1 knock-out (KO), overexpressor (OV) and TbKHC1 knock-down (RNAi) trypanosomes (d: days after doxycyclin induction; ds RNA: double-stranded RNA; histone H2B mRNA: loading control). (B) Detection of TbKHC1 with anti-rTbKHC1 polyclonal antibody in whole extracts from the indicated trypanosome forms (Tub: Tubulin loading control). (C) Parasite staining with anti-PRF monoclonal 2C12 antibody. Nucleus (N) and kinetoplast (K) are stained in blue with 49,6-Diamidino-2-phenylindole (DAPI). (D) Localization of TbKHC1 on WT, KO and OV trypanosomes with anti-rTbKHC1 polyclonal antibody. (E) Immunoprecipitation of TbKHC1, actin, enolase and PDI-2 from 35S-metabolically labelled WT parasite total extracts (1) or supernatants (2). doi:10.1371/journal.ppat.1003731.g002
  • Figure 3. Mechanism of arginase activity induction by T. brucei PRF and rTbKHC1. Myeloid cells from non-infected WT (A-D,F, G) or IL-4Ra KO (E) mice were incubated with PRF or rTbKHC1. (A) IL-10 production induced by PRF. (B) Arginase activity induced by PRF incubated with indicated antibodies or sugars. (C) Arginase activity and IL-10 secretion induced by rTbKHC1 incubated with indicated antibodies or sugars. (D–G) Relative expression level of M2 genes after incubation with rTbKHC1. In F, M2 IL-10-dependent genes are indicated, and in G, rTbKHC1 was incubated with the indicated antibodies. Data are means 6 SEM of 3 individual mice of one representative from 3 independent experiments. * p,0.05 compared to non-stimulated (-) cells. doi:10.1371/journal.ppat.1003731.g003
  • Figure 4. Effects of TbKHC1 on T. brucei growth and infection in mice. (A,B) In vitro parasite growth (A: monomorphic trypanosomes, either WT or induced and non-induced TbKHC1 KD; B: pleomorphic trypanosomes, either WT or TbKHC1 KO and rescued TbKHC1 KO). Data are means 6 SEM of one representative from 3 independent experiments (C,D) Parasitemia in C57Bl/6 mice infected with pleomorphic WT and TbKHC1 KO parasites (C: intraperitoneal injection; D: injection through the bite of infected tsetse flies). Data are means 6 SEM of 4 individual mice of one representative from 6 independent experiments. * p,0.05 comparing TbKHC1 KO- and WT-infected mice. (E–G) TbKHC1-mediated myeloid cell activation. At day 6 p.i. with WT and TbKHC1 KO parasites, mice were treated with anti-IL-10R (anti-IL-10R Ab) or control antibody (Ctrl Ab), and at day 7 spleen myeloid cells were analyzed for arginase activity (E), spontaneous NO secretion (F) and IL-10 secretion (G). Data are means 6 SEM of 3 individual mice of one representative from 3 independent experiments. = p,0.05 comparing WT- or TbKHC1 KO-infected to non-infected mice; £ p,0.05 comparing WT- or TbKHC1 KO-infected mice treated with anti-IL-10R antibody to WT- or TbKHC1 KO-infected control antibody-treated mice; # p,0.05 comparing TbKHC1 KO- and WT-infected mice treated with control antibody. doi:10.1371/journal.ppat.1003731.g004
  • Figure 5. Effects of TbKHC1 on T. brucei parasitaemia. WT and TbKHC1 KO parasitaemias were monitored in various mice and conditions: (A) WT mice treated with L-NAME or D-NAME; (B) iNOS KO and WT mice; (C,D) myeloid cell Arg1 KO mice (KO1 = LysMcreArg1-/lox; KO2 = Tie2creArg1-/lox) and controls (Arg1lox/lox); (E,F) WT mice treated with L-ornithine, D-mannose or D-galactose; (G) MMR KO and WT mice; (H) SIGN-R1 KO and control (Ctrl) mice. Data are means 6 SEM of 4 individual mice of one representative from 3 independent experiments. * p,0.05 comparing D-NAME and L-NAME treated mice (A) or WT and iNOS KO mice (B) infected with WT parasites; = p,0.05 comparing Arg1lox/lox and LysMcreArg1-/lox or Tie2creArg1-/lox mice infected with WT parasites; # p,0.05 comparing L-ornithine treated and non treated mice infected with TbKHC1 KO parasites; ¥ p,0.05 comparing Dmannose and D-galactose-treated mice infected with WT parasites; £ p,0.05 comparing SIGN-R1 KO and control mice infected with WT parasites. doi:10.1371/journal.ppat.1003731.g005
  • Figure 6. SIGN-R1 receptor contribution to myeloid cell activation and liver injury. (A,B) Effects of rTbKHC1 on myeloid cells from noninfected control (Ctrl) or SIGN-R1 KO mice (A: relative expression of Arg1, Arg2, Il10 and iNOS genes; B: arginase activity in presence of indicated antibodies or sugars). Data are means 6 SEM of 3 individual mice of one representative from 3 independent experiments. * p,0.05 compared to non-stimulated (-) cells. (C) Effects of rTbKHC1 on liver injury: microscopic analysis (hematoxylin-eosin staining, magnification 206) of sections from WT- and TbKHC1 KO-infected mice at day 30 p.i. Anoxic infarcts (ai), periportal (..) and lobular (.) mononuclear cell infiltrates were representative of 8 animals tested in 2 independent experiments. (D) Spontaneous NO and IL-10 secretions in spleen myeloid cell supernatants from WT- and TbKHC1 KO-infected mice treated with D-NAME or L-NAME (day 30 p.i.). (E) Idem as D in SIGN-R1 KO and control (Ctrl) mice. Data are means 6 SEM of 3–4 individual mice of one representative from 3 independent experiments. = p,0.05 comparing WT or TbKHC1 KO- infected mice to non-infected mice; £ p,0.05 comparing L-NAME and D-NAME treatment in WT- or TbKHC1 KO-infected mice; # p,0.05 comparing WT- and TbKHC1 KO-infected mice. doi:10.1371/journal.ppat.1003731.g006
  • Table 1. Survival and liver pathology in T. brucei WT- and TbKHC1 KO- infected mice.

References Powered by Scopus

XCMS: Processing mass spectrometry data for metabolite profiling using nonlinear peak alignment, matching, and identification

4040Citations
N/AReaders
Get full text

A tightly regulated inducible expression system for conditional gene knock-outs and dominant-negative genetics in Trypanosoma brucei

1190Citations
N/AReaders
Get full text

Metabolism and functions of trypanothione in the kinetoplastida

712Citations
N/AReaders
Get full text

Cited by Powered by Scopus

Coupling of lysosomal and mitochondrial membrane permeabilization in trypanolysis by APOL1

99Citations
N/AReaders
Get full text

TNF-Mediated Restriction of Arginase 1 Expression in Myeloid Cells Triggers Type 2 NO Synthase Activity at the Site of Infection

96Citations
N/AReaders
Get full text

Thiol redox biology of trypanosomatids and potential targets for chemotherapy

83Citations
N/AReaders
Get full text

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Cite

CITATION STYLE

APA

De Muylder, G., Daulouède, S., Lecordier, L., Uzureau, P., Morias, Y., Van Den Abbeele, J., … Pays, E. (2013). A Trypanosoma brucei Kinesin Heavy Chain Promotes Parasite Growth by Triggering Host Arginase Activity. PLoS Pathogens, 9(10). https://doi.org/10.1371/journal.ppat.1003731

Readers over time

‘13‘14‘15‘16‘17‘18‘19‘20‘21‘22‘23‘250481216

Readers' Seniority

Tooltip

PhD / Post grad / Masters / Doc 29

57%

Researcher 12

24%

Professor / Associate Prof. 7

14%

Lecturer / Post doc 3

6%

Readers' Discipline

Tooltip

Agricultural and Biological Sciences 24

46%

Biochemistry, Genetics and Molecular Bi... 13

25%

Immunology and Microbiology 11

21%

Medicine and Dentistry 4

8%

Save time finding and organizing research with Mendeley

Sign up for free
0